Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 11.36%-1.45M | -51.58%-918.21K | -94.70%-2.34M | -13.96%-5.13M | -41.29%-1.68M | -52.88%-1.64M | 58.79%-605.77K | -56.51%-1.2M | 20.84%-4.5M | 27.47%-1.19M |
| Net income from continuing operations | -23.10%-3.95M | -127.52%-3.13M | -86.52%-2.95M | -39.88%-9.33M | -67.83%-3.17M | -129.17%-3.21M | 18.88%-1.38M | 6.34%-1.58M | 18.64%-6.67M | 16.75%-1.89M |
| Operating gains losses | 144.60%40.07K | 78.72%-11.87K | 97.70%-3.13K | -292.68%-358.64K | -266.88%-183.18K | --16.38K | ---55.78K | ---136.07K | ---91.33K | --109.77K |
| Depreciation and amortization | 0.37%323.57K | 2.25%328.05K | 1.60%325.39K | 15.31%1.29M | -2.61%328.37K | 15.18%322.37K | 27.28%320.84K | 27.52%320.27K | 4.12%1.12M | 16.42%337.17K |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Unrealized gains and losses of investment securities | 430.25%371.18K | --367.5K | --353.5K | --420K | --350K | --70K | --0 | --0 | --0 | ---- |
| Remuneration paid in stock | 313.04%358.87K | 538.05%137.44K | -31.49%195.59K | 13.16%617.62K | 35.18%223.7K | -48.54%86.88K | -78.61%21.54K | 157.82%285.5K | -16.92%545.79K | 33.86%165.48K |
| Deferred tax | --0 | --0 | --0 | -137.04%-490.11K | --0 | --0 | ---390.17K | -87.20%-99.93K | -66.79%-206.76K | -23.73%-153.37K |
| Other non cashItems | 52.35%919.74K | 150.89%1.12M | 190.24%976.82K | 242.98%2.12M | 252.49%739.18K | 270.80%603.69K | 233.59%444.9K | 196.52%336.56K | 205.00%619.38K | 300.84%209.7K |
| Change In working capital | 2.76%480.94K | -35.94%274.59K | -279.52%-1.24M | 226.79%597.47K | -3.11%26.67K | 659.98%468.04K | 264.76%428.67K | -165.30%-325.91K | -68.00%182.83K | -90.29%27.53K |
| -Change in receivables | ---- | 277.58%383.66K | -81.83%-252.46K | ---- | ---- | -392.63%-96.8K | -3,465.10%-216.05K | -191.63%-138.84K | 150.37%81.08K | -550.95%-44.73K |
| -Change in inventory | ---- | ---77.49K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Change in prepaid assets | ---- | -47.12%36.95K | 229.20%147.23K | ---- | ---- | -130.24%-205.53K | 165.06%69.87K | -331.97%-113.96K | -85.72%20.08K | 111.39%33.87K |
| -Change in payables and accrued expense | ---- | -111.92%-68.52K | -1,447.83%-1.13M | ---- | ---- | -951.97%-215.86K | 304.95%574.85K | -124.50%-73.11K | -79.50%81.67K | -85.09%38.39K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 11.36%-1.45M | -51.58%-918.21K | -94.70%-2.34M | -13.96%-5.13M | -41.29%-1.68M | -52.88%-1.64M | 58.79%-605.77K | -56.51%-1.2M | 20.84%-4.5M | 27.47%-1.19M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 63.21%-1.19M | 111.95%470.85K | -193.98%-4.81M | -1,086.88%-18.93M | -703.00%-10.11M | -1,526.57%-3.24M | -164,944.95%-3.94M | -1,119.69%-1.63M | -146.12%-1.59M | -3,325.07%-1.26M |
| Net PPE purchase and sale | 74.21%-1.67M | 52.46%-1.95M | -120.77%-4.08M | -735.58%-19.26M | -227.77%-6.86M | -4,382.29%-6.46M | -44,855.23%-4.09M | -2,297.96%-1.85M | -221.57%-2.31M | -3,904.23%-2.09M |
| Net intangibles purchas and sale | 81.17%-3.17K | -16.78%-5.97K | -15.93%-17.44K | -266.46%-61.5K | -424.12%-24.49K | -364.35%-16.86K | -233.03%-5.11K | -116.62%-15.04K | 35.54%-16.78K | 82.06%-4.67K |
| Net investment purchase and sale | --0 | 81.79%-68.21K | ---- | ---- | ---- | --0 | ---374.6K | ---- | ---- | ---- |
| Net other investing changes | -85.29%475.37K | 366.33%2.49M | -409.50%-707.72K | -45.34%397.62K | ---3.6M | --3.23M | --534.3K | 557.33%228.66K | 665.71%727.43K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 63.21%-1.19M | 111.95%470.85K | -193.98%-4.81M | -1,086.88%-18.93M | -703.00%-10.11M | -1,526.57%-3.24M | -164,944.95%-3.94M | -1,119.69%-1.63M | -146.12%-1.59M | -3,325.07%-1.26M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -82.63%2.58M | -108.76%-361.28K | -122.04%-227.66K | 110.68%26.42M | 285.96%6.43M | 83.77%14.84M | 74.79%4.13M | 133.37%1.03M | 735.93%12.54M | 12.45%1.67M |
| Net issuance payments of debt | -104.79%-721.89K | -99.62%16.09K | -142.19%-449K | 1,321.17%25.83M | 208.24%5.45M | 7,014.26%15.08M | 2,502.01%4.23M | 140.43%1.06M | 142.25%1.82M | 43.73%1.77M |
| Net common stock issuance | --3.37M | 54.67%-12.82K | ---- | -102.85%-74.61K | -45.21%-46.33K | --0 | ---28.28K | ---- | 249.42%2.62M | -104.25%-31.9K |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --8.41M | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --4.06K | --173.5K | --254.35K | --182.36K | --182.36K | --0 | --0 | --0 | --0 | ---- |
| Interest paid (cash flow from financing activities) | 89.29%-26.25K | -619.36%-517.94K | 1.24%-30.86K | -416.45%-905.07K | -673.22%-556.72K | -684.34%-245.11K | 0.00%-72K | ---31.25K | ---175.25K | ---72K |
| Net other financing activities | -3,221.00%-53.65K | -180.87%-20.11K | ---2.15K | 1,158.49%1.39M | --1.39M | 101.96%1.72K | ---7.16K | ---- | ---131.25K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -82.63%2.58M | -108.76%-361.28K | -122.04%-227.66K | 110.68%26.42M | 285.96%6.43M | 83.77%14.84M | 74.79%4.13M | 133.37%1.03M | 735.93%12.54M | 12.45%1.67M |
| Net cash flow | ||||||||||
| Beginning cash position | -63.70%2.04M | -52.34%2.85M | 33.70%10.23M | 586.46%7.65M | 81.99%15.55M | 264.40%5.62M | 813.79%5.99M | 586.46%7.65M | -81.27%1.11M | 590.83%8.55M |
| Current changes in cash | -100.70%-69.74K | -92.76%-808.63K | -308.88%-7.37M | -63.29%2.37M | -583.34%-5.36M | 46.34%9.95M | -147.24%-419.5K | -292.86%-1.8M | 233.30%6.44M | -539.43%-784.93K |
| Effect of exchange rate changes | 101.00%246 | -105.97%-3.33K | -100.40%-567 | 137.28%211.9K | 134.47%38.54K | -112.21%-24.55K | --55.79K | --142.13K | --89.3K | ---111.8K |
| End cash Position | -87.32%1.97M | -63.70%2.04M | -52.34%2.85M | 33.70%10.23M | 33.70%10.23M | 81.99%15.55M | 264.40%5.62M | 813.79%5.99M | 586.46%7.65M | 586.46%7.65M |
| Free cash from | 61.53%-3.12M | 38.99%-2.87M | -110.04%-6.44M | -258.36%-24.45M | -160.50%-8.57M | -564.99%-8.12M | -221.72%-4.71M | -259.89%-3.06M | -6.12%-6.82M | -103.83%-3.29M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.